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Conclusions: iNOS gene expression in human chondrocytes is regulated
at transcription level. iNOS expression is mediated by binding of NF-kB
(p65 homodimers or p65/p50 heterodimers) to the upstream sites of
iNOS enhancer elements (−5.8 kb). Indeed, we show the involvement of
de-methylation in speciﬁc NF-kB enhancer elements in the activation of
iNOS in human OA chondrocytes. These data provide evidence linking
the activation of iNOS, demethylation and induction of the osteoarthritic
process.
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Purpose: Osteoarthritis (OA) is a highly prevalent degenerative joint
disease affecting a large population of elderly people. However, the
detailed molecular mechanisms of this disease are not yet fully elucidated
and there are no effective ways to cure the cartilage breakdown in the
affected sites currently. Over the last few decades, microRNAs have
emerged as a novel class of gene regulators which regulate expression
of more than one third of human genes and play important roles in
pathological states such as cancer, diabetes and arthritis. Previous studies
have provided evidence that miR-146a is expressed in all layers of human
articular cartilage, especially in the superﬁcial zone. However, the exact
etiological mechanism of miR-146a in OA is still an unsolved issue.
The aim of this study is to investigate its role and detailed molecular
mechanism in OA pathology.
Methods: To identify the microRNAs involved in the pathogenesis of
OA, we ﬁrst stimulated primary rat chondrocytes with proinﬂammatory
cytokine IL-1b, an established model to mimic inﬂammation in vitro.
The levels of miR-146a, Smad4 and VEGF were measured by real-
time PCR and Western blotting. Fragments containing 3′UTR of Smad4
were cloned into a luciferase reporter plasmid, luciferase activity
was observed in cells co-transfected with miR-146a and the reporter
plasmids. Function of miR-146a on cell apoptosis was determined by
TUNEL assay. Rat OA model was induced by joint instability, followed by
evaluating histopathologic changes by safranin O staining, and expression
of miR-146a, Smad4 and VEGF were assessed by real-time PCR and
immunohistochemistry.
Results: We found that IL-1b increased miR-146a and VEGF expression,
while Smad4 level was decreased. Smad4 was identiﬁed as direct target
of miR-146a, miR-146a directly regulate Smad4 expression by binding
to Smad4 3′UTR, Up-regulation of VEGF via miR-146a was mediated by
Smad4. miR-146a also induced chondrocyte apoptosis. In OA animal
model, OA cartilage displayed higher level of miR-146a and VEGF
compared with sham group. In contrast, the expression of Smad4 is
lower in OA cartilage compared with sham group.
Conclusions: In this study, we present evidence that miR-146a is up-
regulated in response to OA inﬂammation both in vitro and in vivo, and
Smad4 is a direct target of miR-146a. We also found that the down-
regulation of Smad4 mediated by miR-146a results in an increased
expression of VEGF in chondrocytes, and miR-146a inhibition or Smad4
overexpression reduces VEGF expression. Furthermore, we demonstrated
miR-146a is up-regulated in a surgically induced rat model of OA,
accompanied by down-regulation of Smad4 and up-regulation of VEGF.
Together, these ﬁndings implicate that dysregulation of miR-146a in OA
ultimately leads to pathological angiogenesis in articular cartilage and
accelerates progression of this disease, indicating a possible therapeutic
intervention against OA.
